From the RELATIVITY-047 (NCT03470922) and CheckMate 067 (NCT01844505) trials, what are the most important efficacy and safety data?
Health Professionals
Sex Matters in How, When, and Where Melanomas Develop
Melanoma rates differ consistently between men and women in terms of the ages at which melanomas occur and the locations on the body where they occur.
Early Phase I data shows promise for mRNA cancer immunotherapy in advanced solid cancers
Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers.
‘Simple model’ helps identify melanoma recurrence
Appetite change, tiredness, lymph node enlargement, abdominal pain and shortness of breath were common with melanoma recurrence.